MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr |
What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-12,683 Cr |
| Mar2024 | ₹-2,082 Cr |
| Mar2023 | ₹-1,054 Cr |
| Mar2022 | ₹-1,369 Cr |
| Mar2021 | ₹-1,222 Cr |
How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-12,683 Cr | Negative | |
| Mar2024 | ₹-2,082 Cr | Negative | |
| Mar2023 | ₹-1,054 Cr | Negative | |
| Mar2022 | ₹-1,369 Cr | Negative | |
| Mar2021 | ₹-1,222 Cr | - | |
Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹93,703.5 Cr | 3.2% | 17.9% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.1% | -1.3% | -7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 3% | 7.7% | 7.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.1% | 0.1% | 26.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 9.3% | 6.6% | 12% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 6.8% | 7.7% | -15.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 3.2% |
17.9% |
-12% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses